X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (165) 165
index medicus (121) 121
sydney multicenter (121) 121
male (108) 108
female (105) 105
parkinson's disease (91) 91
clinical neurology (89) 89
middle aged (81) 81
aged (74) 74
adult (52) 52
dementia (52) 52
neurosciences (41) 41
diagnosis (40) 40
risk factors (40) 40
progression (39) 39
aged, 80 and over (38) 38
prevalence (37) 37
gastroenterology & hepatology (36) 36
sydney system (35) 35
disease progression (32) 32
helicobacter pylori (32) 32
mortality (32) 32
risk (32) 32
parkinson disease - complications (29) 29
levodopa (27) 27
parkinson disease - physiopathology (27) 27
adolescent (24) 24
follow-up (24) 24
parkinson disease - drug therapy (24) 24
sydney (24) 24
cancer (23) 23
intestinal metaplasia (23) 23
pathology (22) 22
research (22) 22
classification (21) 21
gastric mucosa - pathology (21) 21
health aspects (21) 21
severity of illness index (21) 21
biopsy (20) 20
psychiatry (19) 19
quality-of-life (19) 19
antiparkinson agents - therapeutic use (18) 18
cohort studies (18) 18
gastritis (18) 18
alzheimers-disease (17) 17
care and treatment (17) 17
endoscopy (17) 17
parkinson disease - diagnosis (17) 17
parkinson disease - therapy (17) 17
population (17) 17
retrospective studies (17) 17
surgery (17) 17
updated sydney system (17) 17
australia (16) 16
parkinsons disease (16) 16
treatment outcome (16) 16
atrophy (15) 15
epidemiology (15) 15
helicobacter-pylori infection (15) 15
prospective studies (15) 15
time factors (15) 15
alpha-synuclein (14) 14
analysis (14) 14
atrophic gastritis (14) 14
cohort (14) 14
cross-sectional studies (14) 14
double-blind (14) 14
follow-up studies (14) 14
gastritis - pathology (14) 14
helicobacter infections - pathology (14) 14
helicobacter pylori - isolation & purification (14) 14
infection (14) 14
neurology (14) 14
neuropsychological tests (14) 14
young adult (14) 14
helicobacter infections - complications (13) 13
lewy bodies (13) 13
longitudinal studies (13) 13
parkinson disease - epidemiology (13) 13
parkinson disease - mortality (13) 13
randomized controlled-trial (13) 13
risk-factors (13) 13
age factors (12) 12
helicobacter infections - drug therapy (12) 12
levodopa - therapeutic use (12) 12
medical research (12) 12
medicine, experimental (12) 12
parkinson disease - psychology (12) 12
prevention (12) 12
quality of life (12) 12
complications and side effects (11) 11
development and progression (11) 11
gastric cancer (11) 11
gastric mucosa - microbiology (11) 11
metaplasia (11) 11
nonmotor symptoms (11) 11
parkinson disease - pathology (11) 11
stomach neoplasms - pathology (11) 11
surveys and questionnaires (11) 11
survival (11) 11
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
DIGESTIVE ENDOSCOPY, ISSN 0915-5635, 05/2013, Volume 25, Issue 3, pp. 264 - 273
Background and Aim Successful eradication of H.pylori changes pathological findings of gastritis dramatically. However, change of endoscopic mucosal findings... 
SURGERY | endoscopic findings | DUODENAL-ULCER | SYDNEY SYSTEM | diffuse redness | CANCER | MUCOSA | RELAPSE | erythema | pylori eradication | HELICOBACTER-PYLORI INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | CAMPYLOBACTER | STOMACH | chronic gastritis | Medical research | Endoscopic surgery | Analysis | Medicine, Experimental | Hemoglobin | Endoscopy | Health aspects | Gastritis
Journal Article
NEUROBIOLOGY OF DISEASE, ISSN 0969-9961, 07/2019, Volume 127, pp. 278 - 286
Objective: Low concentrations of cerebrospinal fluid (CSF) amyloid-beta (A beta-42) are associated with increased risk of cognitive decline in Parkinson's... 
Parkinson's disease | DEMENTIA | INCIDENT | APOE epsilon 4 | Cerebrospinal fluid | ALPHA-SYNUCLEIN | CEREBROSPINAL-FLUID | NEUROSCIENCES | IMPAIRMENT | BIOMARKERS | AMYLOID-BETA | Amyloid | SYDNEY MULTICENTER | ASSOCIATION | PROGRESSION | Cognitive impairment
Journal Article
EXPERIMENTAL BRAIN RESEARCH, ISSN 0014-4819, 02/2019, Volume 237, Issue 2, pp. 435 - 442
Virtually every patient affected by Parkinson's disease (PD) eventually requires treatment with L-3,4-dihydroxyphenylalanine (L-DOPA), which leads to... 
PLACEBO | Parkinson's disease | ANTAGONIST | EMD-281,014 | SEROTONIN 2A RECEPTOR | NEUROSCIENCES | Psychosis | Marmoset | ACP-103 | RITANSERIN | DOUBLE-BLIND | MPTP | SYDNEY MULTICENTER | EMD-281014 | BEHAVIORS | SEVERITY | Dyskinesia
Journal Article
Neurosurgery, ISSN 0148-396X, 12/2018, Volume 83, Issue 6, pp. 1173 - 1182
Abstract BACKGROUND Falls and postural instability (PI) are major sources of morbidity in Parkinson disease (PD). Deep brain stimulation (DBS) is a major... 
Postural instability | Parkinson disease | DBS | Deep brain stimulation | Balance | SURGERY | SUBTHALAMIC NUCLEUS STIMULATION | METHODOLOGY | balance | GAIT | RANDOMIZED-TRIAL | postural instability | SYDNEY MULTICENTER | CLINICAL NEUROLOGY
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 04/2008, Volume 115, Issue 4, pp. 409 - 415
Journal Article
Brain Research Bulletin, ISSN 0361-9230, 09/2018, Volume 142, pp. 78 - 87
Background: Transcranial magnetic stimulation (rTMS) may influence the progression of PD compared with levodopa. The long term mind modification effect of... 
EXECUTIVE FUNCTION | RAT SPINAL-CORD | CORTICAL PLASTICITY | TRANSCRANIAL MAGNETIC STIMULATION | NEUROTROPHIC FACTOR | MOTOR FUNCTION | SYDNEY MULTICENTER | POSITION PAPER | NEUROSCIENCES | LEVODOPA RESPONSE | CLINICAL MEASURES
Journal Article